LYPSTAPLUS is indicated as adjunct to diet for treatment of primary hypercholesterolemia as substitution therapy in adult patients adequately controlled with the individual substances given concurrently at the same dose level as in the fixed dose combination, but as separate products.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
